A Phase II Study of Cisplatin, Pemetrexed and Bevacizumab for Advanced Non-Small Cell (Non squamous cell) Lung Cancer
Not Applicable
- Conditions
- Advanced Non-Small Cell (Non squamous cell) Lung Cance
- Registration Number
- JPRN-UMIN000005763
- Lead Sponsor
- Japanese Foundation for Cancer Research, the Cancer Institute Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
1)Subjects with interstitial pneumonia or pulmonary fibrosis. 2)Uncontrolled Active infection 3)No other active malignancies 4)Concurrent use of steroid therapy 5)Subjects with symptomatic brain metastases. 6)have had or require continuous oral administration of hemostat/have had or require injectable administration of hemostat 7)Uncontrolled pleural. 8)Have received radiation therapy to lesions of lung 9)Have a bleeding diathesis 10)Uncontrolled hypertension 11)Any other reason that,in the opinion of the investugator precludes the subject from participating in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method